Source: Health Canada shortage reports · Updated Jul 23, 2026
Some Rosuvastatin products are in shortage in Canada (9 of 65 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 7, 2026.
A statin used to lower cholesterol and help prevent heart disease.
Products affected
9 / 65
In shortage since
Apr 1, 2017
Est. full return
Aug 7, 2026
Reports on file
325
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-ROSUVASTATIN
20MG · TABLET · APOTEX INC
DIN 02337991 · since Jul 21, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Active shortage
MINT-ROSUVASTATIN
20MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02397811 · since Mar 18, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
MINT-ROSUVASTATIN
10MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02397803 · since Mar 18, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
MINT-ROSUVASTATIN
40MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02397838 · since Mar 18, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
MINT-ROSUVASTATIN
5MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02397781 · since Mar 18, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-ROSUVASTATIN
20MG · TABLET · APOTEX INC
DIN 02337991 · since May 5, 2026, est. end Jun 12, 2026 · Disruption of the manufacture of the drug.
Active shortage
MAR-ROSUVASTATIN
40MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02413108 · since Apr 1, 2017, no end estimate · Delay in shipping of the drug.
Active shortage
MAR-ROSUVASTATIN
40MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02413108 · since Apr 1, 2017, no end estimate · Delay in shipping of the drug.
Active shortage
MAR-ROSUVASTATIN
20MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02413086 · since Apr 1, 2017, no end estimate · Delay in shipping of the drug.
Active shortage
MAR-ROSUVASTATIN
20MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02413086 · since Apr 1, 2017, no end estimate · Delay in shipping of the drug.
Active shortage
MAR-ROSUVASTATIN
10MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02413078 · since Apr 1, 2017, no end estimate · Delay in shipping of the drug.
Active shortage
MAR-ROSUVASTATIN
10MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02413078 · since Apr 1, 2017, no end estimate · Delay in shipping of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Rosuvastatin is currently affected by 9 active shortage reports filed with Health Canada by APOTEX INC, MINT PHARMACEUTICALS INC, MARCAN PHARMACEUTICALS INC.
The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Rosuvastatin is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AA).
Recent changes
Jul 23, 2026
New report filed
Common questions
What is Rosuvastatin used for?
A statin used to lower cholesterol and help prevent heart disease.
When will Rosuvastatin be back in stock in Canada?
The latest manufacturer estimate is Aug 7, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Rosuvastatin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.